|The largest Bulgarian healthcare company Sopharma Trading acquires 100% stakes in Serbian Lekovit
Sopharma Trading, the No 1 company by revenue in the Bulgarian healthcare sector, makes the next step in expanding its operations on the Serbian market and in becoming a strategic investor in the region. The company announces acquisition of minority shares portfolio of Dr. Dragan Petrovic in Lekovit d.o.o. thus becoming an owner of 100% shares in the Serbian pharma distributor.
Looking for scale and continuous dynamic growth, the company started regional expansion by entering Serbian market in May 2015 with initial plans aiming market penetration of exclusive brands portfolio, followed in the summer of 2017 by the acquisition of the majority stakes in the fastest growing Serbian pharma distributor – Lekovit d.o.o. In the last year the Bulgarian investor has focused on the successful integration of the Serbian company as well as on achieving significant growth of operations by both expanding current segments – pharmacy market and developing new business lines – hospital market.
As an innovator, operating in key healthcare segments - wholesale, retail, medical equipment and others Sopharma Trading is planning to implement its successful diversified business model in Serbia and the whole region.
Dimitar Dimitrov, CEO of Sopharma Trading Group stated that “The first step is to become a leader in Serbia by expanding significantly operations and logistics potential. This development will be used as fundament for the regional expansion, since Sopharma Trading sees the whole region of East Europe, especially Balkans, as a vast opportunity for growth”.